ScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ySic74
via IFTTT
Aurobindo recalls hypertensive drug in US citing cancer risk
ScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ySic74
via IFTTT
0 comments:
Post a Comment